✦ LIBER ✦

Phase II trial with high-dose ifosfamide and mesna given in a 24-h infusion for advanced GI tract cancer

✍ Scribed by C. Focan; J. Boossy; D. Focan-Henrard; M. Reginster; J. J. Claessens

Publisher: Springer
Year: 1989
Tongue: English
Weight: 172 KB
Volume: 23
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00267954

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of weekly high dose con

A phase II trial of weekly high dose continuous infusion 5-fluorouracil plus oral leucovorin in patients with advanced colorectal cancer

✍ Enrique Aranda; Andrés Cervantes; Javier Dorta; Esperanza Blanco; Carlos Fernánd 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 2 views

Background. In a previous Phase I1 trial, the authors showed that a weekly continuous infusion of 5-fluorouracil (5-FU) at a dose of 3.5 g/mz for 48 hours is an active treatment for advanced colorectal cancer. The overall response rate was 38.5%, and the median survival was 12 months. These data wer

A phase II trial of oral etoposide with

A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas

✍ Jorge E. Romaguera; M. Alma Rodriguez; Frederick B. Hagemeister; Peter McLaughli 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 491 KB

Continuous infusion of high-dose 5-fluor

Continuous infusion of high-dose 5-fluorouracil in combination with leucovorin and recombinant interferon-alpha-2b in patients with advanced colorectal cancer. A multicenter phase II study

✍ Cornelis J. A. Punt; Jos Th. M. Burghouts; Jelle J. Croles; Peter A. van Liessum 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB 👁 2 views